Healthcare provider profile · identity verified

Kaushik J Doshi, M.D.

Geriatric Medicine · JAMAICA, NY · NPI 1336397629

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	728	225
Amlodipine Besylate	Amlodipine Besylate	650	196
Furosemide	Furosemide	427	122
Gabapentin	Gabapentin	410	115
Metformin Hcl	Metformin Hcl	403	112
Losartan Potassium	Losartan Potassium	334	104
Famotidine	Famotidine	323	88
Tamsulosin Hcl	Tamsulosin Hcl	312	92
Metoprolol Succinate	Metoprolol Succinate	294	85
Metoprolol Tartrate	Metoprolol Tartrate	270	69
Carvedilol	Carvedilol	264	71
Levothyroxine Sodium	Levothyroxine Sodium	263	65
Eliquis	Apixaban	258	74
Lisinopril	Lisinopril	248	69
Rosuvastatin Calcium	Rosuvastatin Calcium	236	69
Clopidogrel	Clopidogrel Bisulfate	221	69
Pantoprazole Sodium	Pantoprazole Sodium	204	81
Finasteride	Finasteride	169	37
Januvia	Sitagliptin Phosphate	165	36
Nifedipine Er	Nifedipine	155	35
Jardiance	Empagliflozin	150	46
Simvastatin	Simvastatin	137	36
Albuterol Sulfate Hfa	Albuterol Sulfate	134	47
Isosorbide Mononitrate Er	Isosorbide Mononitrate	125	29
Hydrochlorothiazide	Hydrochlorothiazide	105	39
Lantus	Insulin Glargine,hum.Rec.Anlog	103	15
Silodosin	Silodosin	100	14
Fluticasone Propionate	Fluticasone Propionate	97	44
Silver Sulfadiazine	Silver Sulfadiazine	90	29
Ammonium Lactate	Ammonium Lactate	88	36
Allopurinol	Allopurinol	87	27
Mirtazapine	Mirtazapine	87	22
Hydralazine Hcl	Hydralazine Hcl	83	25
Alendronate Sodium	Alendronate Sodium	81	31
Diclofenac Sodium	Diclofenac Sodium	80	34
Spironolactone	Spironolactone	80	22
Latanoprost	Latanoprost	73	24
Metformin Hcl Er	Metformin Hcl	71	19
Ramipril	Ramipril	71	17
Levetiracetam	Levetiracetam	68	15
Repaglinide	Repaglinide	68	14
Meloxicam	Meloxicam	65	33
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	64	23
Vitamin D2	Ergocalciferol (Vitamin D2)	64	18
Carbidopa-Levodopa	Carbidopa/Levodopa	63	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	25
Triamcinolone Acetonide	Triamcinolone Acetonide	61	32
Warfarin Sodium	Warfarin Sodium	60	suppressed
Lactulose	Lactulose	59	23
Escitalopram Oxalate	Escitalopram Oxalate	57	14
Prednisolone Acetate	Prednisolone Acetate	56	suppressed
Humalog	Insulin Lispro	55	suppressed
Entresto	Sacubitril/Valsartan	54	13
Omeprazole	Omeprazole	54	21
Donepezil Hcl	Donepezil Hcl	53	26
Prednisone	Prednisone	51	29
Tramadol Hcl	Tramadol Hcl	51	20
Amiodarone Hcl	Amiodarone Hcl	48	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	48	48
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	14
Novolog Flexpen	Insulin Aspart	47	17
Azelastine Hcl	Azelastine Hcl	46	19
Lokelma	Sodium Zirconium Cyclosilicate	45	14
Shingrix	Varicella-Zoster Ge/As01b/Pf	45	25
Memantine Hcl	Memantine Hcl	44	13
Xarelto	Rivaroxaban	44	12
Folic Acid	Folic Acid	42	15
Trazodone Hcl	Trazodone Hcl	42	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	41	12
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Ozempic	Semaglutide	39	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	38	14
Cefdinir	Cefdinir	37	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	11
Meclizine Hcl	Meclizine Hcl	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Enulose	Lactulose	35	suppressed
Symbicort	Budesonide/Formoterol Fumarate	35	13
Enalapril Maleate	Enalapril Maleate	34	suppressed
Atenolol	Atenolol	33	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	33	17
Ezetimibe	Ezetimibe	32	16
Chlorhexidine Gluconate	Chlorhexidine Gluconate	31	suppressed
Ranolazine Er	Ranolazine	31	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	31	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	13
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	28	13
Lansoprazole	Lansoprazole	28	suppressed
Lidocaine	Lidocaine	28	15
Mupirocin	Mupirocin	28	suppressed
Risperidone	Risperidone	28	suppressed
Single Use Swab	Alcohol Antiseptic Pads	28	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Cilostazol	Cilostazol	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Novolog	Insulin Aspart	27	suppressed
Niacin Er	Niacin	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	23	14
Tresiba	Insulin Degludec	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	14
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Hydrocortisone	Hydrocortisone	22	12
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Valsartan	Valsartan	21	12
Calcitriol	Calcitriol	20	suppressed
Clotrimazole	Clotrimazole	20	11
Farxiga	Dapagliflozin Propanediol	20	12
Azithromycin	Azithromycin	19	17
Lacosamide	Lacosamide	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Glipizide	Glipizide	18	suppressed
Novolin N	Insulin Nph Human Isophane	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Procrit	Epoetin Alfa	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Bromfenac Sodium	Bromfenac Sodium	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Entacapone	Entacapone	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Topiramate	Topiramate	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Clonidine	Clonidine	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	14	suppressed
Retacrit	Epoetin Alfa-Epbx	14	suppressed
Ssd	Silver Sulfadiazine	14	suppressed
Tiotropium Bromide	Tiotropium Bromide	14	suppressed
Baclofen	Baclofen	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	11
Naproxen	Naproxen	13	13
Bicalutamide	Bicalutamide	12	suppressed
Ciclopirox	Ciclopirox Olamine	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Levemir	Insulin Detemir	11	suppressed
Nexletol	Bempedoic Acid	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error